These results demonstrate that prolonged JNK and p38 activation is pro-apoptotic in NPC, CRC, and gastric cancer, and by inactivating JNK and p38, DUSP16 is part of the strategy employed by these cancer cells in intrinsic or acquired cisplatin resistance. Here, DUSP16 is linked to cancer.